NM5072 is an anti-Properdin antibody that selectively blocks the alternative pathway while maintaining the integrity of the classical pathway required for fending off infections
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
PREVENAR offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of currently circulating pneumococcal disease in the EU and globally
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Subscribe To Our Newsletter & Stay Updated
